Cervical trophoblasts for non-invasive single-cell genotyping and prenatal diagnosis
2016
Abstract Objective We aimed at developing a method to recover
trophoblastic cellsfrom the cervix through a completely non-invasive approach and obtaining a genetic proof of their fetal nature implying that they can be used for non-invasive prenatal diagnosis (NIPD). Methods We studied obstetrical samples from 21 pregnant women between 8 and 12 weeks of gestation scheduled for
chorionic villus samplingor undergoing elective termination of pregnancy. A cytobrush was used to extract cells from the external parts of the cervix and transferred to 10 ml of preservative solution. Cells were layered on filters with 8 microns pores using the ISET system (Isolation by SizE of Tumor/
Trophoblastic cells) and stained. Putative fetal cells were collected by single cell laser-assisted
microdissectionand identified as fetal or maternal cells by Short Tandem Repeat genotyping. NIPD was blindly performed on 6 mothers at risk of having a fetus with Cystic Fibrosis or
Spinal Muscular Atrophy. Results
Trophoblastic cellswere recovered from all tested cervical samples with a frequency of 2–12
trophoblastsper 2 ml. NIPD was blindly obtained and verified in 6 mothers at risk of having a fetus with Cystic Fibrosis or
Spinal Muscular Atrophy. Discussion Although larger confirmation studies are required, this is the first report providing a solid proof of principle that
trophoblastscan be consistently and safely recovered from cervical samples. Since they are a source of pure fetal DNA, i.e. fetal DNA not mixed with maternal DNA, they constitute an ideal target to develop NIPD of recessive diseases, which is a technical challenge for methods based on cell free DNA.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
36
References
24
Citations
NaN
KQI